Hospital for Sick Children

Making an impact together: Peninsula Canada teams up with SickKids Hospital to drive positive change.

Retrieved on:

Thursday, March 28, 2024

Health, HR, Partnership, Hospital, Hospital for Sick Children, Better World, Corporation, Nursing

TORONTO, March 28, 2024 /CNW/ - Peninsula Canada, a global leading HR and health & safety firm, committed to making a positive impact in the community, is proud to announce a partnership with SickKids Foundation, a leading charity dedicated to supporting The Hospital for Sick Children (SickKids).

Key Points:

TORONTO, March 28, 2024 /CNW/ - Peninsula Canada, a global leading HR and health & safety firm, committed to making a positive impact in the community, is proud to announce a partnership with SickKids Foundation, a leading charity dedicated to supporting The Hospital for Sick Children (SickKids).
Together, we aim to create an impact on the health of children locally, nationally, and around the world.
This alliance aligns with Peninsula's core value and mission of making a meaningful difference in the lives of individuals and communities.
"We are thrilled to partner with Peninsula Canada to help drive forward our vision of Healthier Children.

Record number of Northern Ontario families seek support from Hope Air to reach medical care far from home

Retrieved on:

Thursday, February 1, 2024

Partnership, Ovarian cancer, Meal, Mental health, Travel, Atmosphere of Earth, Government, Princess Margaret Cancer Centre, Patient, Private sector, Poverty, Volunteering, Hospital for Sick Children, Hope Air, Hospital, Nursing

Demand for Hope Air programs for Ontario patients increases 165% in 2023 to 3,367 travel arrangements for patients in need to reach critical medical care.

Key Points:

Demand for Hope Air programs for Ontario patients increases 165% in 2023 to 3,367 travel arrangements for patients in need to reach critical medical care.
TORONTO, Feb. 1, 2024 /CNW/ - Hope Air, Canada's national charity providing travel support to patients in financial need who must travel far from home to access vital medical care, announced an all-time annual record high in travel arrangement support for residents of Ontario.
Hope Air programs support the policies of government that are committed to reducing poverty and improving access to health care.
Over 800,000 people reside in Northern Ontario, far from advanced medical care provided by hospitals such as Sick Kids Hospital and Princess Margaret Cancer Centre.

Pizza Nova raises $15,000 for SickKids Foundation as part of its holiday campaign

Retrieved on:

Wednesday, January 17, 2024

Hospital for Sick Children, Sale, Partnership, Patient, Causality, Research, Health, Social media

On January 16 Pizza Nova presented a cheque to Alex Chiarlitti, Manager, Cause Marketing, and Stacey Robinson, Director of Cause Marketing at the SickKids Foundation at SickKids Hospital in downtown Toronto.

Key Points:

On January 16 Pizza Nova presented a cheque to Alex Chiarlitti, Manager, Cause Marketing, and Stacey Robinson, Director of Cause Marketing at the SickKids Foundation at SickKids Hospital in downtown Toronto.
"We value every opportunity we have to partner with SickKids Foundation and support their lifesaving and life-enriching work," says Domenic Primucci, president of Pizza Nova.
Rian and Qais, SickKids Foundation ambassadors and patients of SickKids Hospital were the faces of the SickKids Foundation campaign.
"We are grateful to Pizza Nova for its leadership and support," says Stacey Robinson, Director of Cause Marketing at SickKids Foundation.

CHS Global Partnerships for Research & Innovation Awards Four Research Grants to Institutions Leading Research to Improve the Quality of Life for Deaf and Hard of Hearing Individuals

Retrieved on:

Wednesday, January 10, 2024

TORONTO, Jan. 10, 2024 (GLOBE NEWSWIRE) -- CHS Global Partnerships for Research & Innovation, a non-profit organization and strategic global leader in the advancement of research and innovation that improves the quality of life for Deaf and hard of hearing individuals, is excited to announce that it has awarded four additional research grants to institutions leading research that will break down barriers to participation for Deaf and hard of hearing individuals and their families. Since its launch in January 2022, CHS Global Partnerships for Research & Innovations has proudly awarded a total of $782,425 in research grants.

Key Points:

Since its launch in January 2022, CHS Global Partnerships for Research & Innovations has proudly awarded a total of $782,425 in research grants.
Each of the winning research projects has the potential to unlock new insights and breakthroughs in the field of hearing health and Deaf studies.
By supporting cutting-edge research, CHS Global Partnerships for Research & Innovation, aims to contribute not only to the global scientific community but, most importantly, to deliver on our mission of improving the lives of Deaf and hard of hearing individuals.
Results from this research will define a novel way to improve hearing for children using cochlear implants.

Bunzl Canada’s Annual Week of Giving Supports Local Communities

Retrieved on:

Tuesday, December 19, 2023

Hospital, Culture, Partnership, Food, Homelessness, Marketing, Wildfire, Health, Hospital for Sick Children, Heart, Communication, Bunzl, Food Banks Canada, Organization, Hygiene, Tissue paper

BURLINGTON, Ontario, Dec. 19, 2023 (GLOBE NEWSWIRE) -- Bunzl Canada is pleased to announce its third annual Week of Giving, in partnership with Food Banks Canada, to provide much needed personal care, hygiene and safety products to foodbanks across Canada during one of the most critical times of the year.

Key Points:

In May, Bunzl Canada delivered necessary cleaning and hygiene products to 1,500 evacuees impacted by wildfires in Alberta and Northwest Territories.
"We're thrilled to have completed our third annual Week of Giving.
Bunzl Canada is made up of local businesses with longstanding connections to the communities we serve,” said Margo Hunnisett, Vice President of Marketing and Communications.
“This event highlights our commitment to investing in and participating actively in our communities across the country."

GROUNDBREAKING PARTNERSHIP UNVEILED: CANADA'S LEADING PAEDIATRIC HOSPITALS AND THE AZRIELI FOUNDATION JOIN FORCES TO TRANSFORM CHILDREN'S HEALTHCARE IN CANADA

Retrieved on:

Monday, December 11, 2023

Doctor of Philosophy, Research, DNA, Azrieli Center, Biology, David Azrieli, Hospital, CHU, Genomics, Health, Child, Partnership, Quality of life, Environment, Hospital for Sick Children, Nursing

SickKids and CHU Sainte-Justine are two of North America's largest child health research hospitals, with combined coverage of 61 per cent of Canada's paediatric population.

Key Points:

SickKids and CHU Sainte-Justine are two of North America's largest child health research hospitals, with combined coverage of 61 per cent of Canada's paediatric population.
Further, these internationally recognized institutions will focus their ambitions on three innovation pillars: genomics, novel therapies, and rich research data.
With these frameworks in place, the Foundation has now invested an additional $50 million to accelerate this transformational vision for personalized child healthcare.
"Today marks a pivotal moment in Canadian healthcare history as we embark on a new era of delivering personalized, paediatric care," said Naomi Azrieli, O.C., DPhil, Chair and CEO of the Azrieli Foundation.

Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay™ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)

Retrieved on:

Monday, November 13, 2023

ZUG, Switzerland and PARIS, Nov. 13, 2023 /PRNewswire/ -- Today, Ipsen (Euronext: IPN) (ADR: IPSEY), a global biopharmaceutical company focused on transformative medicines in oncology, rare disease and neuroscience, and Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in international markets, are pleased to announce the Health Canada approval for Bylvay™ (odevixibat) for the treatment of pruritus in patients aged 6 months or older with Progressive Familial Intrahepatic Cholestasis (PFIC), a progressive and life-threatening liver disease. Bylvay is the first medication approved in Canada for the treatment of pruritus in patients aged six months or older with PFIC.

Key Points:

Bylvay is the first medication approved in Canada for the treatment of pruritus in patients aged six months or older with PFIC.
"At Medison, accelerating patients' access to innovative treatments is leading all that we do, so we are pleased and proud to bring Bylvay to patients in Canada," said Gil Gurfinkel, CEO at Medison Pharma.
"Until today, surgery was the only treatment option available for PFIC patients," said Mr. Walter Perez, President, Progressive Familial Intrahepatic Cholestasis Advocacy and Resource Network and father of a child living with PFIC.
We are extremely pleased that a less invasive treatment option is now available."

Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay™ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)

Retrieved on:

Monday, November 13, 2023

ZUG, Switzerland and PARIS, Nov. 13, 2023 /PRNewswire/ -- Today, Ipsen (Euronext: IPN) (ADR: IPSEY), a global biopharmaceutical company focused on transformative medicines in oncology, rare disease and neuroscience, and Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in international markets, are pleased to announce the Health Canada approval for Bylvay™ (odevixibat) for the treatment of pruritus in patients aged 6 months or older with Progressive Familial Intrahepatic Cholestasis (PFIC), a progressive and life-threatening liver disease. Bylvay is the first medication approved in Canada for the treatment of pruritus in patients aged six months or older with PFIC.

Key Points:

Bylvay is the first medication approved in Canada for the treatment of pruritus in patients aged six months or older with PFIC.
"At Medison, accelerating patients' access to innovative treatments is leading all that we do, so we are pleased and proud to bring Bylvay to patients in Canada," said Gil Gurfinkel, CEO at Medison Pharma.
"Until today, surgery was the only treatment option available for PFIC patients," said Mr. Walter Perez, President, Progressive Familial Intrahepatic Cholestasis Advocacy and Resource Network and father of a child living with PFIC.
We are extremely pleased that a less invasive treatment option is now available."

Twenty-one grants awarded to support trainees across Canada

Retrieved on:

Wednesday, October 25, 2023

MONTREAL, Oct. 25, 2023 (GLOBE NEWSWIRE) -- In an effort to support the next generation of brain researchers in Canada, Brain Canada is thrilled to present the 21 trainees who have received grants to help launch their academic careers and pursue their professional goals. The Brain Canada Rising Stars Trainee Awards aim to recognize the excellent research being conducted at Canadian institutions by graduate students (M.Sc., Ph.D.), postdoctoral fellows, and medical residents in all fields spanning neuroscience research.

Key Points:

MONTREAL, Oct. 25, 2023 (GLOBE NEWSWIRE) -- In an effort to support the next generation of brain researchers in Canada, Brain Canada is thrilled to present the 21 trainees who have received grants to help launch their academic careers and pursue their professional goals.
“Supporting trainees through specialized programs designed for the next generation of scholars is a fundamental aspect of Brain Canada's mission,” says Dr. Viviane Poupon, President and CEO of Brain Canada.
"We are delighted to announce the expansion of our support through the Brain Canada Rising Stars Trainee Awards this year, demonstrating our commitment to nurturing the next era of exceptional brain researchers."
"Brain Canada's support of trainees and early career researchers is clearly responding to a need, and the continued commitment to enable capacity-building programs is more important now than ever."

Sailun Launches Winter Campaign with Generous Donation to SickKids Hospital

Retrieved on:

Monday, October 2, 2023

Partnership, Hospital for Sick Children, Health, Safety, Nursing

Toronto, Ontario, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Sailun Tire, a leading global tire manufacturer, is proud to announce the launch of its exciting new winter campaign.

Key Points:

Toronto, Ontario, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Sailun Tire, a leading global tire manufacturer, is proud to announce the launch of its exciting new winter campaign.
Sailun will continue to educate consumers on the necessity of having dedicated winter tires during the harsh Canadian winter as well as the features and benefits of our Ice Blazer winter tires that are trusted by 1+ million Canadians and counting.
We aim to make a meaningful difference in the lives of children and families in need with a generous donation to SickKids Hospital to support the incredible work they do for children's health.
"At Sailun, we believe in giving back to the community and supporting the well-being of children and families,” said Ron Dolan, President, Sailun Tire North America.